| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | China | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | United States | 4 | |
| #5 | Brazil | 3 | |
| #6 | Canada | 3 | |
| #7 | United Kingdom | 3 | |
| #8 | Republic of Korea | 3 | |
| #9 | Mexico | 3 | |
| #10 | Hong Kong | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | O'Dwyer Michael Eamon Peter | 19 |
| #2 | Hu Jinsong | 6 |
| #3 | Sarkar Subhashis | 4 |
| #4 | Michael Eamon Peter O'Dwyer | 4 |
| #5 | Michael Eamon Peter O''Dwyer | 3 |
| #6 | Jinsong Hu | 2 |
| #7 | O`Dwyer Michael Eamon Peter | 2 |
| #8 | Odwyer Michael Eamon Peter | 1 |
| #9 | O'Dwyer Michael | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2019321402A1 | Nk cells for use with anitbodies in cancer therapy | |
| CN111788301A | Modified natural killer cells and natural killer cell lines targeting tumor cells | |
| GB201806463D0 | Cancer therapy | |
| US2018344768A1 | Nk cell-based therapy | |
| MX2018001074A | Modified natural killer cells and natural killer cell lines having increased cytotoxicity. | |
| GB201610164D0 | Modified natural killer cells and natural killer cell lines having increased cytoxicity | |
| GB201603655D0 | Modified natural killer cells and natural killer cell lines having increased cytotoxicity |